I n humans measles is believed t o confer lifelong immune protection against reexposure t o measlesvirus (MV), which appears largely based on persistence o f M V neutralizing (VN) antibodies and the presence of M V specific cytotoxic T lymphocytes (CTL). Apart from humans several nonhuman primate species can be infected with MV. However, the pathogenesis of this infection and the basis of immune protection in these animals is largely unknown. Here w e show that cynomolgus monkeys (Macaca fascicularis) can be experimentally infected w i t h a wild-type strain of measlesvirus (MV-BIL), that has recently been isolated from an outbreak of measles in school children in The Netherlands. Following intratracheal inoculation w i t h different infectious doses, the virus could be isolated from peripheral blood mononuclear cells (PBMC), lung lavage cells and pharyngeal cells. Specific serum IgM, IgG and neutralizing antibody responses as well as MV-specific T cell mediated immunity were induced, quite similar t o responses observed in infected children. Monkeys vaccinated with attenuated measles vaccine (MVSchwartz) also showed a PBMC associated viraemia and specific IgM responses. They proved t o be protected from intratracheal infection w i t h MV-BIL 9 months after immunization. This model is currently used for the evaluation of new generations of vaccines and vaccination strategies In the framework of a WHO vaccine evaluation program. (2) Recently, w e observed an outbreak of measles among highschool children in The Netherlands, where 2 3 out of 9 4 9 children developed clinical measles. The virus w a s isolated, which, on the basis of nucleotide sequence analysis, appeared t o be closely related t o the wild-type M V strains that had circulated in Europe and the USA in 1989. Blood samples were collected from 1 0 cases w i t h clinical measles and from 3 7 children who exhibited only part of the symptoms ( n = 3 3 ) or were clinically healthy (n=4). The simultaneous evaluation of antibody and T cell mediated measles virus (MV) specific immune responses allowed a more accurate identification of individuals w i t h M V infection than the evaluation of specific antibody responses alone (IgM or IgG or both). On basis of the presence of M V specific IgA and of CD8+ CTL, i t was concluded that 2 9 of the 4 7 children investigated had recently been infected with MV. Of these 29 children, 2 4 had a documented history of live M V vaccination. The replication of M V In individuals vaccinated w i t h live attenuated measles vaccine may thus have implications for future M V eradication strategies.
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MEASLES INVACCINATED HIGHSCHOOLCHILDREN AS EVIDENCED BY SPECIFIC
Maternally Derived Antibodies Against RSV.
N. Craig, A. Brandenburg, Ph.H. Rothbarth. Department of Virology, University Hospital Rotterdam RSV-bronchiolitis is the predominant cause of severe respiratory tract infection in the first year of live, especiallv in the first 6 months when maternally derived antibodies are/ present. In this study we analyzed the decay of maternally derived antibodies to RSV. Sera of 44 children. taken at 0. 3 and 6 months of age, born in the period of march to/ june, were tested. In a western blot antibodies of IgG subclasses llgG1.2. 3 and 41 against structural protein of RSV (fusionprotein (F). glycoprotein (GI, Nucleocapsid (N) and phosphoprotein (PI w e r i tested. Direct neutralizing antibodies were tested in a microneutralisation assay. All Children had aniibodies of the IgG class at birth. In the western blot IgGl antibodie showed the same pattern as IgG total. lgG2 was less often detectable. IgG3 and for wer only detectable in one serum each, both sera taken at 0 months. This is in good agreemen with the usual ratios of IgG subclasses in blood. Probably the westem blot is not sensitiv enough to detect lgG3 and 4 because of competition with abundant IgG1. Peter R m n a l d , Jchan F Schoemm, Wda*Beyers, Sophia M C a r l i n i , Kurt D olsen,* George H ma-acken. F a e l i a t r i c s and C h i l d Health, U n i v e r s i t y Stellenbssch, Tyqerberg 7505 South A f r i c a and P a d a t r i a , V n i v e r s i t y o f Tews, Southwestern Medical Center, Dallas, USA.* CSF INE -tratim were determined o n 76 occasions in 30 children (mean age 27.4 months) w i t h ?BM a t varying i n t e r v a l s during the f i r s t mxlth o f treatment. Zhe mean m n c e n t r a t i o n during the lst week of theraw was 780 ~/ m l f a l l i n g to 554 m/ml i n t h e 2 r d week, 529 m/ml i n the 3 r d week ard 269 m/ml i n t h e 4 t h week.
TNFa and VrU concentrations w e r e determind in 23 of t h e s e chilcken on 56 -ions. m a w a s p r e s e n t in low, b u t detectable, ooncentraticm thraqhcut the first month of therapy w i t h m e a n concentrations of 17.15 m/ml, 11.39 pq/ml, 11.08 w/ml anJ. Conclu~lon. 'l'hc study proved to he internally validated by demonstrating tile expectcd el'ti-ct of RSV-ah. The data on Hep2-ah poinl on a role for these preexlcttng autoreactivc ah i n the pathogenesis o f RSV infection.
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Epidemiology a n d microbiology of congenital bacterial infections in VLBWinfants w i t h respiratory failure. ~i t h GBS and E. coli as the most freouentlv isolated aerms. These findinos have to be considered with respecl to timing and sel&ionbf antimic;obkl therapy.
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